FDA Warns Consumers to Beware Bogus Diabetes Treatments

Images of bogus diabetes treatments courtesy of the FDA. The U.S. Food and Drug Administration (FDA) is warning diabetics to beware of illegal “natural” remedies for the treatment of diabetes. They pose a serious health danger to diabetics, and are part of the growing trend amongst drug counterfeiters pushing fake natural medications. The FDA has…

[...]

Fake Botox on the Rise in US as FDA Warnings and Recent Arrest Indicate

In 2012, the FDA sent over 350 warning letters to doctors advising them they may have purchased fraudulent or misbranded injectable drugs, including fake versions of Avastin, Botox, and two different osteoporosis treatments. Now the FDA has identified another batch of fake Botox that is currently being marketed to doctor via fax blast.

On April 26, 2013, the US Food and Drug Administration (FDA) posted a drug safety warning for healthcare practitioners, warning them that fraudulent versions of the anti-wrinkle treatment Botox are being marketed and sold in the US. The Botox is being sold by unlicensed suppliers, and has not been vetted within the secure U.S. supply chain. They state that the FDA “cannot confirm that the manufacture, quality, storage, and handling of these products follow U.S. standards. These fraudulent products are considered unsafe and should not be used.

[...]

FDA Warns Consumers Not to Use Stolen Advair Inhalers

The U.S. Food and Drug Administration (FDA) has issued a warning that a number of Advair Diskus inhalers that were stolen in 2009 have been found in some pharmacies and that consumers should not used the stolen products. The products were reported stolen from a GlaxoSmithKline warehouse near Richmond, Virginia, in August 2009. These recently…

[...]

FDA Warns of Online H1N1 Influenza Virus Drug Product Purchases

FDA is alerting you to a use extreme caution when purchasing any medication over the Internet claiming to prevent or treat H1N1 influenza virus. Several orders of the H1N1 vaccine Tamiflu (oseltamivir) purchased from online pharmacies were found to be a health threat to consumers.

[...]

Dangerous Assumptions Drawn From List of Permitted Countries

Periodically proposals are floated both in Washington, DC and state capitols that would allow Americans to import drugs from 32 “permitted” countries – Australia, Canada, Japan, New Zealand, Switzerland and the 27 members of the European Union. There is a perception that these countries have “safe” drug supplies insulated from the dangers that every other nation in the world.

[...]

FDA MedWatch Safety Alert: Nationwide Recalls of Dietary Supplement Stamina-Rx

Posted June 22, 2009 Nationwide Recalls of Dietary Supplement Stamina-Rx Unapproved Ingredient Present in Supplement  Food and Drug Administration (FDA) and Hi-Tech Pharmaceuticals notified patients and healthcare professionals of a nationwide recall of all products sold under the name Stamina-Rx.  FDA lab analysis found that the product contained the undeclared ingredient − benzamidenafil.  Benzamidenafil is…

[...]

Cheerios… A Threat Larger Than Counterfeit Drugs?

On May 5, the U.S. Food and Drug Administration (FDA) administered a warning against General Mills regarding the claim that Cheerios® Toasted Whole Grain Oat Cereal has the ability to lower cholesterol. Basically, the FDA cited General Mills for marketing Cheerios® as a cholesterol-reducing drug. I believe the FDA’s points are valid and factual, but I have to ask – Shouldn’t our agency watchdog be focusing greater attention on the operators of thousands of Web sites and

[...]

Is Drug Safety in the U.S. Moving in the Right Direction?

Protecting the public’s health is an important part of the part of the U.S. Food and Drug Administration (FDA) job. And on May 7, the FDA proposed several measures that would allow the agency to better regulate the safety of Americans’ food and medical products. The FDA request for the President’s fiscal year 2010 budget asks for $3.2 billion to protect and promote public health. This figure, which is a 19 percent increase from the current FDA fiscal year budget, is a significant step towards the direction of a safer pharmaceutical supply chain.

[...]